• otv

News Highlights

  • Establishing the source and destination of these medicines would come under the purview of investigation,

  • No patient is deprived of the medicines and the required treatment, Mohapatra said.

  • A special squad of Drugs Control yesterday had seized nearly 17,000 fake anti-viral drug Favipiravir following a raid at a pharmacy in Cuttack

Bhubaneswar: A day after the State Drugs Control squad seized huge quantities of fake anti-covid drugs 'Favipiravir' in Cuttack, the State Health department has ordered a probe into the incident on Saturday.

The Drugs Controller and Police will carry out a joint investigation into the transaction of spurious medicines and submit a report, informed PK Moahapatra, Additional chief secretary, Health Department

Establishing the source and destination of these medicines would come under the purview of investigation, he added.

The Health Department is claimed to have provided adequate medicines to the hospitals for the treatment of Covid patients. No patient is deprived of the medicines and the required treatment, Mohapatra said.

A special squad of Drugs Control had seized nearly 17,000 fake anti-viral drug Favipiravir following a raid at a pharmacy in Cuttack on Friday.

As many as 170 boxes of the counterfeit drugs consignment were seized from a chemist shop at Kanika Chhak in the millennium city.

State Drugs Controller, Annada Sankar Das had said the raid was conducted based on intelligence input regarding the sale of such counterfeit drugs.

The spurious medicines were seized before the stock was released in the open market in Odisha.

Preliminary probe indicates that the owner of the medicine store has sent parts of the stock to Gwalior.

“We have already informed the Madhya Pradesh government about the incident for appropriate action,” said Das.

The State Drugs Controller further informed that the fake drugs were procured from Uttar Pradesh by the Cuttack-based outlet.

The squad would send samples of the seized spurious Favipiravir tablets to laboratories for tests, Das had informed.

Other Stories